These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3682414)

  • 1. Changes in vascular responsiveness to vasoactive agents in the hindlimb of DOCA-salt hypertensive rats.
    Sogabe K; Uematsu T; Hashimoto H; Ozaki T; Nakashima M
    Jpn J Pharmacol; 1987 Aug; 44(4):502-5. PubMed ID: 3682414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
    Nunes VW; Fortes ZB; Nigro D; Carvalho MH; Zorn TM; Scivoletto R
    Gen Pharmacol; 2000 Feb; 34(2):117-25. PubMed ID: 10974419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroprusside-induced vascular relaxation in DOCA hypertensive rats.
    Cohen DM; Webb RC; Bohr DF
    Hypertension; 1982; 4(1):13-9. PubMed ID: 7061120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitter release, vascular responsiveness and their suppression by Ca-antagonist in perfused mesenteric vasculature of DOCA-salt hypertensive rats.
    Tsuda K; Kuchii M; Nishio I; Masuyama Y
    Clin Exp Hypertens A; 1986; 8(2):259-75. PubMed ID: 3720003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate-salt rat.
    Soltis EE; Field FP
    Hypertension; 1986 Jun; 8(6):526-32. PubMed ID: 3710558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular responses to serotonin in steroid hypertensive rats.
    Mecca TE; Webb RC
    Hypertension; 1984; 6(6 Pt 1):887-92. PubMed ID: 6519745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater calmodulin-dependent regulation of neurotransmitter release and vascular responsiveness in chronic Doca-salt hypertension.
    Tsuda K; Tsuda S; Goldstein M; Masuyama Y
    Am J Hypertens; 1989 Feb; 2(2 Pt 1):93-8. PubMed ID: 2537092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary L-arginine attenuates blood pressure in mineralocorticoid-salt hypertensive rats.
    Laurant P; Demolombe B; Berthelot
    Clin Exp Hypertens; 1995 Oct; 17(7):1009-24. PubMed ID: 8556001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter release, vascular responsiveness and their calcium-mediated regulation in perfused mesenteric preparation of spontaneously hypertensive rats and DOCA-salt hypertension.
    Masuyama Y; Tsuda K; Kusuyama Y; Hano T; Kuchii M; Nishio I
    J Hypertens Suppl; 1984 Dec; 2(3):S99-102. PubMed ID: 6599723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats.
    Hagen EC; Webb RC
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H409-14. PubMed ID: 6383078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin antagonist reduces hemodynamic responses to vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; Wilson TW; McNeill JR
    Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2511-7. PubMed ID: 11709418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension.
    Adeagbo AS; Joshua IG; Falkner C; Matheson PJ
    Eur J Pharmacol; 2003 Nov; 481(1):91-100. PubMed ID: 14637180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
    Tsuda K; Masuyama Y
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonate metabolites and serotonin contraction of femoral arteries from DOCA-salt hypertensive rats.
    Kanagy NL; Mecca TE; Webb RC
    Blood Press; 1996 Mar; 5(2):113-20. PubMed ID: 8860100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral vascular responsiveness in deoxycorticosterone acetate-salt hypertensive rats.
    Soltis EE; Bohr DF
    Am J Physiol; 1987 Jan; 252(1 Pt 2):H198-203. PubMed ID: 3812710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular reactivity to angiotensin and noradrenaline in rats maintained on a sodium free diet or made hypertensive with desoxycorticosterone acetate and salt (DOCA/salt).
    Couture R; Regoli D
    Clin Exp Hypertens (1978); 1980; 2(1):25-43. PubMed ID: 7418541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular reactivity of perfused vascular bed in spontaneously hypertensive and normotensive rats.
    Bhattacharya BK; Dadkar NK; Dohadwalla AN
    Br J Pharmacol; 1977 Feb; 59(2):243-6. PubMed ID: 837012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorthalidone reduces vascular hyperresponsiveness in DOCA-salt hypertensive rats.
    Cabral AM; Musso MN; Bissoli NS; Carvalhinho FB; Vasquez EC
    Clin Exp Hypertens A; 1992; 14(4):667-83. PubMed ID: 1628412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.